Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2454 of 6351
-
Promising combo for tough breast cancer hits snag: trial ends early
Disease control Stopped earlyThe goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with nab-paclitaxel or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in participants with non-surgically removable locally adv…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Bubble burst breakthrough: ultrasound may boost bile duct cancer therapy
Diagnosis CompletedThis phase II trial tests whether contrast-enhanced ultrasound can predict the response of bile duct cancer to targeted radiotherapy (radioembolization treatment). Contrast-enhanced ultrasound uses gas microbubbles that may provide enhancement on ultrasound. It is also possible t…
Phase 2 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Could a new drug finally silence chronic cough?
Symptom relief CompletedCough is the most common presenting symptom to family physician. Chronic Cough affects approximately 10-12% of the general population and is one of the commonest reasons for referral to secondary care. Unfortunately, there are no licensed treatments for this debilitating conditio…
Phase 4 • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 26, 2026 17:49 UTC
-
Can a drug combo help smokers ditch cigarettes for E-Cigs?
Disease control CompletedThis three-group randomized double-blind placebo-controlled trial (N=180) will evaluate the impact of combination zonisamide and bupropion on the process of switching from combustible cigarettes (CCs) to an e-cigarette. There will be a data collection period of at least five days…
Phase 3 • Sponsor: Rose Research Center, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could one drug replace two after a heart attack stent?
Disease control CompletedA pilot study planned to evaluate initial safety of ticagrelor monotherapy after coronary stenting due to acute myocardial infarction. The study is a single-centre, single-arm, prospective phase II study 200 patients who undergo coronary artery stenting due to NSTEMI or STEMI wi…
Phase 2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Scientists track rare ataxia to unlock future treatments
Knowledge-focused Recruiting nowThis international, multi-center, multi-modal and prospective observational study aims to determine the phenotypic spectrum and the natural progression of the RFC1 repeat expansion disease, and to seek and validate digital, imaging, and molecular biomarkers that aid in diagnosis …
Sponsor: Prof. Dr. Matthis Synofzik • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New depression pill shows promise in large trial
Symptom relief Recruiting nowThis is a phase 2 and 3 adaptive design study for Mitizodone Phosphate,to find out an optimal dose in phase 2 period and confirm the result an efficacy and safety in phase 3 period.Dose-finding will be done after 8 weeks of double-blinded treatment in phase 2 period and will be a…
Phase 2/3 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Absorbable chest scaffold aims to reshape sunken sternum without metal
Disease control CompletedThe clinical study is testing a new treatment for pectus excavatum called "custom-made 3D printed scaffold-based soft tissue reconstruction". The new method uses a combination of the patients own adipocytes (fat cells) with a 3D printed scaffold (PCL Pectus Scaffold) to support s…
Sponsor: BellaSeno Pty Ltd • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
What are cancer patients taking on their own? a nationwide survey seeks answers
Knowledge-focused CompletedThe purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Experimental cancer drug GEN1047 tested in humans – study halted early
Disease control Stopped earlyThe purpose of this trial is to measure the following in participants with solid tumors who receive GEN1047: * The side effects seen with GEN1047 * What the body does with GEN1047 once it is administered * What GEN1047 does to the body once it is administered * How well GEN1047 …
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a bladder drug and an ED drug fix prediabetes?
Disease control Recruiting nowThe investigator hypothesizes that treatment with the ß3 agonist mirabegron results in improved glucose metabolism, including a reversal of prediabetes in obese, insulin-resistant human research participants, and this is further improved by combination therapy with tadalafil. The…
Phase 4 • Sponsor: Philip Kern • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a simple program boost life satisfaction for those with mild cognitive impairment?
Symptom relief CompletedThe investigators developed and tested the Daily Engagement in Meaningful Activities (DEMA) intervention to improve life satisfaction and health outcomes for patients and caregivers. DEMA is a positive health focused, theoretically grounded, tailored, family-centered, multi-facet…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New drug hope for rare sarcomas after chemo fails
Disease control OngoingThe purpose is to evaluate the effectiveness and safety of Surufatinib in patients with osteosarcoma and soft tissue sarcoma after Standard chemotherapy therapy.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New light therapy could zap stubborn acne without pills
Disease control CompletedThe aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) for the medication Ameluz® performed with the PDT-lamp BF-RhodoLED® in comparison to the respective placebo treatment for moderate to severe Acne vulgaris.
Phase 2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control Stopped earlyAn investigation of the safety and efficacy of tildacerfont in participants with CAH.
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Brain bleed breakthrough? new study tests antidote for blood thinner patients
Knowledge-focused CompletedThe multicenter, prospective, observational, non-interventional study conducted in German Stroke Units is investigating patients with intracranial hemorrhage (ICH) under effective anticoagulation with rivaroxaban or apixaban. The aim of the study is to analyze under routine cond…
Sponsor: University Hospital, Essen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New flu vaccine shows promise in south korean trial
Vaccine Completed* To describe the immune response induced by quadrivalent recombinant influenza vaccine (RIV4) and Quadrivalent-inactivated Influenza Vaccine (IIV4) in 18-49 and greater than or equal to (\>=) 50 years of age participants by hemagglutination inhibition (HAI) measurement method. *…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 15:35 UTC
-
New scan could sharpen detection of childhood cancer
Diagnosis Recruiting nowNeuroblastoma is the most frequent extracranial childhood tumor, with an annual incidence of approximately 10.2 per million children. Staging of the disease can be done by different imaging strategies (CT, MRI, scintigraphy and PET/CT). Discrepancies may be observed among these d…
Phase 2 • Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New ultrasound technique could reveal hidden cancer spread in pancreatic patients
Diagnosis CompletedNowadays pancreatic cancer is one of the deadliest oncological pathologies. The only effective curative tool is the surgery. Before the intervention, an endoscopic ultrasound is performed on the patient to carry out the biopsy of the main tumor. In this study, the echoendoscopie …
Sponsor: IHU Strasbourg • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Can an aspirin injection work faster than a pill?
Knowledge-focused CompletedThe purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.
Phase 1 • Sponsor: Rhoshan Pharmaceuticals Inc • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC